Skip to search formSkip to main contentSkip to account menu

novolimus

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • H. NefJ. Wiebe C. Hamm
  • Catheterization and cardiovascular interventions
  • 2018
  • Corpus ID: 3670644
To date, experience with bioresorbable scaffolds (BRS) that elute agents other than everolimus is limited. Thus, a post‐marketing… 
2018
2018
Bioresorbable coronary scaffolds (BRS) have been developed to increase the late safety of coronary angioplasty by providing… 
Review
2017
2016
2016
AIMS Newer-generation drug-eluting stents (DES) have been shown to be superior to first-generation DES. Current-generation DES… 
Review
2016
Review
2016
  • A. Dalal
  • World journal of transplantation
  • 2016
  • Corpus ID: 15813515
Patients listed for organ transplant frequently have severe coronary artery disease (CAD), which may be treated with drug eluting… 
Review
2013
Review
2013
Highly Cited
2010
Highly Cited
2010
AIMS Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents… 
2010
2010
Owing to their marked efficacy in reducing restenosis, drug-eluting stents currently represent the predominant strategy for… 
2008
2008
AIMS First generation DES have markedly reduced restenosis. However, there is a major interest in developing new DES with greater…